"10.1371_journal.pone.0068633","plos one","2013-07-04T00:00:00Z","Adrienne Shnier; Joel Lexchin; Barbara Mintzes; Annemarie Jutel; Kelly Holloway","Health Policy and Equity, School of Health Policy and Management, York University, Toronto, Canada; School of Health Policy and Management, York University, Toronto, Canada; University Health Network, Toronto, Canada; Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Canada; School of Population and Public Health, University of British Columbia, Vancouver, Canada; Graduate School of Nursing Midwifery and Health, Victoria University of Wellington, Wellington, New Zealand; Department of Sociology, York University, Toronto, Canada","Conceived and designed the experiments: JL. Performed the experiments: AS JL BM AJ KH. Analyzed the data: AS JL BM AJ KH. Wrote the paper: AS JL BM AJ KH.","In 2007 Joel Lexchin was a consultant to a law firm acting for Apotex Inc. In 2008 he was an expert witness for the Canadian federal government in its defence against a lawsuit challenging the ban on direct-to-consumer advertising. In 2010 he was an expert witness for a law firm representing the family of a plaintiff who allegedly died from an adverse reaction from a product made by Allergan. He is currently on the Management Board of Healthy Skepticism Inc. and is the Chair of the Health Action International - Europe Association Board. Barbara Mintzes is on the Health Action International - Europe Association Board. Joel Lexchin and Barbara Mintzes are Academic Editors at PLOS ONE. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials. The other authors report no conflicts of interest.","2013","07","Adrienne Shnier","AS",5,TRUE,1,5,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
